DK558283A - Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf, farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling - Google Patents

Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf, farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling Download PDF

Info

Publication number
DK558283A
DK558283A DK558283A DK558283A DK558283A DK 558283 A DK558283 A DK 558283A DK 558283 A DK558283 A DK 558283A DK 558283 A DK558283 A DK 558283A DK 558283 A DK558283 A DK 558283A
Authority
DK
Denmark
Prior art keywords
compounds
heteroazolide
indion
spiro
intermediates
Prior art date
Application number
DK558283A
Other languages
Danish (da)
English (en)
Other versions
DK558283D0 (da
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK558283D0 publication Critical patent/DK558283D0/da
Publication of DK558283A publication Critical patent/DK558283A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK558283A 1982-12-06 1983-12-05 Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf, farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling DK558283A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06
US06/545,450 US4556670A (en) 1982-12-06 1983-10-28 Spiro-3-hetero-azolones for treatment of diabetic complications

Publications (2)

Publication Number Publication Date
DK558283D0 DK558283D0 (da) 1983-12-05
DK558283A true DK558283A (da) 1984-07-11

Family

ID=27034944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK558283A DK558283A (da) 1982-12-06 1983-12-05 Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf, farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling

Country Status (21)

Country Link
US (1) US4556670A (ko)
EP (1) EP0115133B1 (ko)
KR (1) KR860001581B1 (ko)
AU (1) AU545409B2 (ko)
BG (1) BG44708A3 (ko)
CA (1) CA1204763A (ko)
DD (1) DD219482A5 (ko)
DE (1) DE3379043D1 (ko)
DK (1) DK558283A (ko)
ES (1) ES527780A0 (ko)
FI (1) FI80267C (ko)
GR (1) GR78787B (ko)
IE (1) IE56345B1 (ko)
IL (1) IL70379A (ko)
NO (1) NO160001C (ko)
NZ (1) NZ206484A (ko)
PH (1) PH19622A (ko)
PL (1) PL142143B1 (ko)
PT (1) PT77760B (ko)
RO (1) RO88202B (ko)
YU (1) YU43557B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159143B1 (en) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4575507A (en) 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
JP2005523314A (ja) 2002-04-18 2005-08-04 ユニバーシティ オブ バージニア パテント ファウンデーション 新規ナトリウムチャンネル遮断化合物
WO2004050039A2 (en) * 2002-12-04 2004-06-17 Merck & Co., Inc. Spirocyclic ureas, compositions containing such compounds and methods of use
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
PH19622A (en) 1986-05-30
CA1204763A (en) 1986-05-20
KR860001581B1 (ko) 1986-10-10
PT77760B (en) 1986-05-30
PT77760A (en) 1983-12-01
IL70379A (en) 1988-10-31
IE832854L (en) 1984-06-06
BG44708A3 (ko) 1989-01-16
NO834437L (no) 1984-06-07
YU43557B (en) 1989-08-31
DE3379043D1 (en) 1989-03-02
RO88202B (ro) 1985-12-31
IL70379A0 (en) 1984-03-30
FI80267C (fi) 1990-05-10
NO160001B (no) 1988-11-21
EP0115133A1 (en) 1984-08-08
NO160001C (no) 1989-03-01
FI834457A0 (fi) 1983-12-05
IE56345B1 (en) 1991-07-03
DD219482A5 (de) 1985-03-06
NZ206484A (en) 1987-07-31
AU2196883A (en) 1984-06-14
GR78787B (ko) 1984-10-02
EP0115133B1 (en) 1989-01-25
YU237183A (en) 1986-02-28
PL244966A1 (en) 1985-05-21
RO88202A (ro) 1985-12-30
US4556670A (en) 1985-12-03
FI834457A (fi) 1984-06-07
DK558283D0 (da) 1983-12-05
FI80267B (fi) 1990-01-31
ES8601912A1 (es) 1985-11-16
AU545409B2 (en) 1985-07-11
KR840006975A (ko) 1984-12-04
ES527780A0 (es) 1985-11-16
PL142143B1 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
DK142485A (da) Acyltripeptider, mellemprodukter ved deres fremstilling og farmaceutiske praeparater
NO860141L (no) Tiazolidindionderivater og fremgangsmaate for deres fremstilling.
DK110886A (da) Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne
DK422485A (da) 1,3-diacyl-2-oxindol-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutiske praeparater
DK170785D0 (da) 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK590586A (da) 5-amino- og 5-hydroxy-6,8-difluorquinoloner og salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
DK394489A (da) I para-stillingen heterocyclisk substituerede n-phenylamidforbindelser, mellemprodukter ved deres fremstilling, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af antiarytmiske laegemidler
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK166018C (da) N-oe2-(4-fluorphenyl)-1-methyl)-ethyl-n-methyl-n-propynylamin, isomere og salte deraf, deres fremstilling og farmaceutiske praeparater indeholdende dem
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK461389A (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK404879A (da) Kortikoid-21-sulfopropionater og deres salte fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
DK531387A (da) 3-propenylcephemderivater, mellemprodukter til anvendelse ved fremstillingen heraf og praeparater indeholdende foerstnaevnte forbindelser.
NO813808L (no) Glycinderivat, fremgangsmaate ved fremstilling og farmasoeytiske blandinger derav
DK558283D0 (da) Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf,farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling
DK172183D0 (da) Ozazolderivater, deres fremstilling og anvendelse
DK488385D0 (da) N6-bicycloadenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser
DK340388A (da) Aminocyklopentylaetere, fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DK314283D0 (da) Farmaceutiske praeparater
NO830966L (no) Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
DK439588D0 (da) Beta-lactamer, fremgangsmaade til deres fremstilling, mellemprodukter til brug derved og farmaceutiske praeparater indeholdende forbindelserne
DK240984A (da) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
NO831901L (no) 3-(ureidocykloheksylamino)-propan-1,2-diolderivater, fremgangsmaater til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse
DK427285A (da) 2-(n-heterocyclyl)penemer, deres fremstilling og farmaceutiske anvendelse
IT8567216A0 (it) Composti pteridinici relativi procedimenti di preparazione e preparati farmaceutici che li contengono

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment